Selma Su, Sophia Neman, Naomi Fields, Douglas Luchristt, C Emi Bretschneider
{"title":"Association of Minimally Invasive Hysterectomy Route at the Time of Sacrocolpopexy with Postoperative Complications.","authors":"Selma Su, Sophia Neman, Naomi Fields, Douglas Luchristt, C Emi Bretschneider","doi":"10.1007/s00192-025-06175-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction and hypothesis: </strong>Minimally invasive sacrocolpopexy (SCP) with concomitant minimally invasive hysterectomy (MIH) is a frequently employed reconstructive surgical treatment for pelvic organ prolapse; however, the literature is limited regarding how the route of MIH affects postoperative adverse events. This study was aimed at investigating the association of route of MIH at the time of minimally invasive SCP and 30-day postoperative adverse events.</p><p><strong>Methods: </strong>This was a retrospective cohort study using the American College of Surgeons National Surgical Quality Improvement database to compare perioperative adverse events for patients who underwent minimally invasive SCP with MIH for uterovaginal prolapse. MIH included total laparoscopic hysterectomy (TLH), laparoscopic supracervical hysterectomy (SCH), laparoscopy-assisted vaginal hysterectomy (LAVH) and total vaginal hysterectomy (TVH). Perioperative adverse events of the four routes of MIH were compared.</p><p><strong>Results: </strong>During the study period, 7690 patients were identified. TLH was the most common route of MIH (56%), followed by laparoscopic SCH (39%), TVH (3%), and LAVH (2%). The rate of any 30-day adverse event was 10% and rates were similar between MIH groups. On multivariate logistic regression controlling for confounders, there were no significant differences in rates of postoperative adverse events between MIH groups.</p><p><strong>Conclusion: </strong>Adverse events following MIH at the time of SCP are not associated with the route of hysterectomy.</p>","PeriodicalId":14355,"journal":{"name":"International Urogynecology Journal","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Urogynecology Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00192-025-06175-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction and hypothesis: Minimally invasive sacrocolpopexy (SCP) with concomitant minimally invasive hysterectomy (MIH) is a frequently employed reconstructive surgical treatment for pelvic organ prolapse; however, the literature is limited regarding how the route of MIH affects postoperative adverse events. This study was aimed at investigating the association of route of MIH at the time of minimally invasive SCP and 30-day postoperative adverse events.
Methods: This was a retrospective cohort study using the American College of Surgeons National Surgical Quality Improvement database to compare perioperative adverse events for patients who underwent minimally invasive SCP with MIH for uterovaginal prolapse. MIH included total laparoscopic hysterectomy (TLH), laparoscopic supracervical hysterectomy (SCH), laparoscopy-assisted vaginal hysterectomy (LAVH) and total vaginal hysterectomy (TVH). Perioperative adverse events of the four routes of MIH were compared.
Results: During the study period, 7690 patients were identified. TLH was the most common route of MIH (56%), followed by laparoscopic SCH (39%), TVH (3%), and LAVH (2%). The rate of any 30-day adverse event was 10% and rates were similar between MIH groups. On multivariate logistic regression controlling for confounders, there were no significant differences in rates of postoperative adverse events between MIH groups.
Conclusion: Adverse events following MIH at the time of SCP are not associated with the route of hysterectomy.
期刊介绍:
The International Urogynecology Journal is the official journal of the International Urogynecological Association (IUGA).The International Urogynecology Journal has evolved in response to a perceived need amongst the clinicians, scientists, and researchers active in the field of urogynecology and pelvic floor disorders. Gynecologists, urologists, physiotherapists, nurses and basic scientists require regular means of communication within this field of pelvic floor dysfunction to express new ideas and research, and to review clinical practice in the diagnosis and treatment of women with disorders of the pelvic floor. This Journal has adopted the peer review process for all original contributions and will maintain high standards with regard to the research published therein. The clinical approach to urogynecology and pelvic floor disorders will be emphasized with each issue containing clinically relevant material that will be immediately applicable for clinical medicine. This publication covers all aspects of the field in an interdisciplinary fashion